Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

11118	Companies
244805	Keywords
172884	Articles
131993	Press releases

Home
Companies
Theranexus

BRIEF

published on 09/29/2026 at 18:05, 4 days ago

THX Pharma Releases Financial Results for H1 2026

Financial Results Revenue Growth Neurological Diseases THX Pharma Biocodex Partnership
BRIEF

published on 09/29/2026 at 18:05, 4 days ago

THX Pharma Publishes its First Half 2026 Results

Half-year Results Batten-1 Rare Neurological Diseases THX Pharma Biocodex Agreement
PRESS RELEASE

published on 09/29/2026 at 18:00, 4 days ago

THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026
THX Pharma announces financial results for the six-month period ended June 30, 2026, showcasing revenue generation and strategic partnerships for rare neurological disease treatments

Financial Results Clinical-Stage Biopharmaceutical Batten-1 Rare Neurological Diseases THX Pharma
BRIEF

published on 09/09/2026 at 08:35, 24 days 10 hours ago

European Patent Secures Batten-1's Future in Juvenile Batten Disease Treatment

Orphan Drug Designation Batten-1 Juvenile Batten Disease European Patent THX Pharma
BRIEF

published on 09/09/2026 at 08:35, 24 days 10 hours ago

A European Patent for Batten-1 Strengthens its Protection

Batten-1 Batten Disease European Patent Miglustat Protection
PRESS RELEASE

published on 09/09/2026 at 08:30, 24 days 10 hours ago

Corrected press release : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 in Juvenile Batten Disease (CLN3)
THX Pharma and Beyond Batten Disease Foundation secure European patent EP 4 188 371 for Batten-1 in juvenile Batten disease (CLN3), reinforcing long-term exclusivity strategy

Batten-1 Juvenile Batten Disease European Patent THX Pharma Beyond Batten Disease Foundation
BRIEF

published on 09/08/2026 at 18:05, 25 days ago

THX Pharma and BBDF strengthen the protection of Batten-1 in Europe

Batten-1 Batten Disease European Patent Miglustat THX Pharma
BRIEF

published on 09/08/2026 at 18:05, 25 days ago

THX Pharma Secures European Patent for Batten-1

Intellectual Property Orphan Drug Designation Batten-1 Juvenile Batten Disease European Patent
PRESS RELEASE

published on 09/08/2026 at 18:00, 25 days ago

THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 in Juvenile Batten Disease (CLN3)
THX Pharma and BBDF announce European patent grant for Batten-1 treatment of juvenile Batten disease, ensuring long-term exclusivity through 2041

Batten-1 BBDF Juvenile Batten Disease European Patent THX Pharma
BRIEF

published on 09/01/2026 at 18:05, 1 month 2 days ago

Submission of applications for authorization for the Batten-1 clinical trial

Phase 3 Batten-1 Batten Disease THX Pharma Biocodex

Accesswire

Published on 10/03/2026 at 02:35, 16 hours 12 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 1 hour ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 1 day 4 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 5 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 5 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/03/2026 at 15:45, 3 hours 2 minutes ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 18 hours 52 minutes ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 22 hours 23 minutes ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 23 hours ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 1 day 1 hour ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 1 day 1 hour ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 1 day 23 hours ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE